56
Participants
Start Date
June 30, 2007
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008
"A single 0.5mL dose of Novartis adjuvanted subunit influenza vaccine, Fluad contained 45μg of viral hemagglutinin, composed of 15μg of the three influenza antigens:~* A(H1N1) strain: IVR-145 (Solomon Island/3/2006 - like strain)~* A(H3N2) strain: NYMC X-161B (A/Wisconsin/67/2005-like strain)~* B strain: (B/Malaysia/2506/2004-like strain) in accordance with the recommendations of the World Health Organization, the EU and the national Regulatory Agencies for the 2007/2008 season.~The vaccine is a milky liquid, and was packaged in ready to use, single dose syringes.~A single dose of FLUAD vaccine was administered intramuscularly, preferably in the deltoid muscle of the non dominant arm."
Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, Via S. Spaventa, 37, Lanciano
Dipartimento di Medicina e Scienze dell'Invecchiamento, Chieti
Lead Sponsor
Novartis Vaccines
INDUSTRY